Nephron names John Singerling to SAB
13 March 2019 -

Generic inhalation company Nephron Pharmaceuticals Corporation revealed on Tuesday the addition of John Singerling, III as the inaugural member of its newly established Senior Advisory Board.

The company disclosed that the mission of this board is to promote generic medication usage to lower the rising cost of healthcare and promote opioid free pain management as a solution to the current US crisis. Singerling's extensive background in hospital administration and years of healthcare service uniquely qualify him as an industry strategist.

Since joining Palmetto Health in 1996, Singerling has served as its administrative fellow, chief operating officer at Palmetto Health Richland, president of Palmetto Health as well as president of Prisma Health-Midlands.

According to the company, Singerling graduated from the USC graduate programme in Health Administration.